A study to examine the association between serum vitamin D levels and genetic variation of VDR and dopamine-specific genes in Attention Deficit Hyperactivity Disorder (ADHD)
- Conditions
- Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
- Registration Number
- CTRI/2024/08/072003
- Lead Sponsor
- Amrita Institute of Medical Sciences and Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1A. Healthy children (Controls): Children with no current medical illness and family history of any major psychiatric disorder, especially ADHD as defined by ICD-10/ DSM-V.
1B. ADHD patients (Cases): Children diagnosed with ADHD by the paediatrician and the clinical psychologist using the Vanderbilt ADHD rating scale and who are on therapy or not. Comorbid with ODD, SLD, and CD will be included.
2. Willing to withdraw blood and participate in the study after giving consent.
3. Responsible caregiver to provide sufficient information about the participant’s functional status.
1. History of any neurological disorder and psychiatric conditions involving the brain or other central function (eg: History of brain injury, suspected intellectual disability, autism spectrum disorder, narcolepsy, H/O mental retardation (MR), schizophrenia, mania episode, epilepsy, anxiety disorders, bipolar disorder, active suicidal ideation)
2. Use of Anticoagulants
3. Having any serious medical condition, including inflammatory bowel disease, history of cancer, kidney or liver disease, hyperthyroidism, glaucoma, diabetes or cardiovascular disorders, gallstones, bile duct obstruction, stomach ulcers, or excess stomach acid, abnormality of mineral metabolism eg: Wilson’s disease, hemochromatosis
4. Having any disability that would interfere with participation in the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method